This company is a global pharmaceutical manufacturer with a focus on developing and manufacturing a wide range of high-quality injectable medicines. They provide a diverse product portfolio encompassing tablets, capsules, injectables, dry syrups, liquids, drops, creams, and inhalers. The company operates in the European Union and North America, demonstrating compliance with international quality standards. Their dedication to innovation and customer satisfaction is reflected in their in-house design department and their commitment to providing cost-effective solutions and reliable supply chains. Key therapy areas include cardiology, oncology, and infectious diseases, though other areas are also likely addressed. The company has a history of providing custom manufacturing solutions and research and development services, highlighting their expertise in the industry.
Manufacturer usually replies in 7 days
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.